Ke-Hsin Hsu

Title: Innovations by Ke-Hsin Hsu in Electrogram Ablation

Introduction

Ke-Hsin Hsu is a notable inventor based in Jhongli, Taiwan. He has made significant contributions to the field of medical technology, particularly in the area of electrogram ablation. His work focuses on improving the treatment of ventricular fibrillation, a critical condition that can lead to severe health complications.

Latest Patents

Hsu holds a patent for a system and method for improved complex fractionated electrogram ablation. This innovative approach involves a computer-assisted method for the quantitative characterization and treatment of ventricular fibrillation. The process includes preprocessing a time series of an atrial fibrillation signal obtained from a patient, segmenting the time series into activation segments, obtaining local activation waveforms (LAW) from these segments, determining degrees of similarity between the LAWs, and identifying critical regions in the patient's atria if the LAWs exceed a certain threshold of similarity. Hsu's patent represents a significant advancement in the field of cardiac treatment.

Career Highlights

Ke-Hsin Hsu is affiliated with National Central University, where he continues to engage in research and development in medical technologies. His work has garnered attention for its potential to enhance patient outcomes in cardiac care. Hsu's dedication to innovation in this field is evident through his patent and ongoing research efforts.

Collaborations

Hsu collaborates with esteemed colleagues, including Men-Tzung Lo and Yenn-Jiang Lin. Their combined expertise contributes to the advancement of medical technologies and the development of effective treatment methods.

Conclusion

Ke-Hsin Hsu's contributions to the field of electrogram ablation highlight the importance of innovation in medical technology. His patent and collaborative efforts demonstrate a commitment to improving patient care and advancing the understanding of complex cardiac conditions.